Withdrew 14 (23.0%) 1 0 (16.1%) 24 (19.5%) Reason for withdrawal Withdrawal of consent 2 (3.3%) 0 (0.0%) 2 (1.6%) Adverse event 6 (9.8%) 7 (11.3%) 13 (10.6%) Investigator decision 0 (0.0%) 0 (0.0%) 0 (0.0%) Protocol violation 2 (3.3%) 1 (1.6%) 3 (2.4%) Lost to follow-up 0 (0.0%) 0 (0.0%) 0 (0.0%) Administrativea4 (6.6%) 2 (3.2%) 6 (4.9%) aIncluded discontinuation of study site participation in the study. Mean ±SD. Copyright 2004 John Wiley & Sons, Ltd. Diabetes Metab Res Rev 2004; 20: 411–417.